x

Search for a clinical trial

* (*) mandatory field

38 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member = ; Member of a ERN =

National clinical trial(s)

AUSTRIA

WIEN
WIEN

Recruiting trial
Ongoing trial
High Risk Neuroblastoma Study 1 of SIOP-Europe (SIOPEN) (Phase III) - AT
St. Anna Kinderspital
Zentrum für Kinder- und Jugendheilkunde

AUSTRIA

WIEN
WIEN

Recruiting trial
Ongoing trial
LINES: European Low and Intermediate Risk Neuroblastoma Protocol (Phase III) - AT
St. Anna Kinderspital
Zentrum für Kinder- und Jugendheilkunde

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Bayern
REGENSBURG

Recruiting trial
Ongoing trial
INFORM2 NivEnt: exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies
Universitätsklinikum Regensburg
Abteilung für Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation

GERMANY

Mecklenburg-Vorpommern
GREIFSWALD

GERMANY

Nordrhein-Westfalen
ESSEN

Recruiting trial
Ongoing trial
INFORM2 NivEnt: exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies
Universitätsklinikum Essen
Klinik für Kinderheilkunde III - Abteilung für pädiatrische Hämatologie und Onkologie

GERMANY

Nordrhein-Westfalen
KÖLN

IRELAND

County Dublin
DUBLIN

Ongoing trial
A randomised phase IIb trial of bevacizumab added to temozolomide ± irinotecan for children with refractory/relapsed neuroblastoma - BEACON-Neuroblastoma Trial - IE
Children's Health Ireland @ Crumlin
National Oncology/ Bone Marrow Transplant Centre and Haematology Department

SPAIN

Comunidad Valenciana
VALENCIA

Recruiting trial
Ongoing trial
European Low and Intermediate Risk Neuroblastoma Protocol (Phase III) - ES
IIS La Fe - Instituto de Investigación Sanitaria La Fe
Grupo de investigación clínica y traslacional en cáncer

SPAIN

Comunidad Valenciana
VALENCIA

Recruiting trial
Ongoing trial
BEACON-Neuroblastoma Trial: A randomised phase IIb trial of bevacizumab added to temozolomide ± irinotecan for children with refractory/relapsed neuroblastoma - ES
IIS La Fe - Instituto de Investigación Sanitaria La Fe
Grupo de investigación clínica y traslacional en cáncer

UNITED KINGDOM

Greater London
LONDON

Recruiting trial
Ongoing trial
NB 2002 06: High Risk Neuroblastoma Study 1 Of Siop-Europe (Phase III) - UK
University College London Hospitals, NHS Foundation Trust
The Somers Clinical Research Facility Level 1

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Ongoing trial
STEP: Sorafenib Long Term Extension Program - BE
Cliniques universitaires Saint-Luc - UCLouvain
Pneumologie_Oncologie thoracique

Multinational clinical trial(s)